Cohlhepp Ryan Insider Trades

Insider Trading History

Track insider trading activity for Cohlhepp Ryan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $5.51M 196,141 shares
Last Trade
May 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$254k 12,500 shares
$20.29
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $5.74M 204,141 shares
Last Trade
May 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$162k 8,000 shares
$20.23
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $2.85M 101,334 shares
Last Trade
May 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$162k 8,000 shares
$20.23
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $5.86M 208,641 shares
Last Trade
Apr 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$184k 8,000 shares
$22.98
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $5.64M 200,641 shares
Last Trade
Apr 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$288k 12,500 shares
$23.01
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $3.07M 109,334 shares
Last Trade
Apr 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$184k 8,000 shares
$22.98
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $5.99M 213,141 shares
Last Trade
Mar 16, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$155k 8,000 shares
$19.40
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $5.76M 205,141 shares
Last Trade
Mar 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$246k 12,500 shares
$19.66
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $3.3M 117,334 shares
Last Trade
Mar 16, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$155k 8,000 shares
$19.40
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $5.89M 209,641 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$316k 17,392 shares
$18.16
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $6.25M 222,533 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$231k 12,892 shares
$17.92
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $3.52M 125,334 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$231k 12,892 shares
$17.92
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $3.88M 138,226 shares
Last Trade
Feb 25, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$54.4k 3,108 shares
$17.51
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $5.91M 210,164 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$65.5k 3,631 shares
$18.04
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $5.99M 213,272 shares
Last Trade
Feb 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$54.4k 3,108 shares
$17.51
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $8.43M 300,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.03M 300,000 shares
$16.76
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $5.91M 210,164 shares
Last Trade
Jan 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$69.3k 3,828 shares
$18.10
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $6.01M 213,992 shares
Last Trade
Jan 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.68k 149 shares
$18.02
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $1.12M 39,909 shares
Last Trade
Dec 26, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$420k 25,000 shares
$16.80
$28.10
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
President And COO
Holding Value $6.02M 214,141 shares
Last Trade
Dec 26, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$420k 25,000 shares
$16.80
$28.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up